cbdMD, Inc. (YCBD-PA)
- Previous Close
1.5200 - Open
1.5200 - Bid 1.4600 x 1200
- Ask 1.5700 x 800
- Day's Range
1.5000 - 1.5600 - 52 Week Range
0.3100 - 1.5799 - Volume
99,010 - Avg. Volume
14,707 - Market Cap (intraday)
-- - Beta (5Y Monthly) 2.59
- PE Ratio (TTM)
-- - EPS (TTM)
-0.5030 - Earnings Date May 13, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.
www.cbdmd.com42
Full Time Employees
September 30
Fiscal Year Ends
--
Sector
--
Industry
Recent News: YCBD-PA
View MorePerformance Overview: YCBD-PA
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: YCBD-PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: YCBD-PA
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-13.99%
Return on Assets (ttm)
-10.96%
Return on Equity (ttm)
-60.98%
Revenue (ttm)
19.22M
Net Income Avi to Common (ttm)
-6.69M
Diluted EPS (ttm)
-0.5030
Balance Sheet and Cash Flow
Total Cash (mrq)
1.97M
Total Debt/Equity (mrq)
91.23%
Levered Free Cash Flow (ttm)
4.89M